U.S. Physical Therapy, Inc. (USPH) - Q1 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025. U.S. Physical Therapy, Inc. operates through two reportable segments: Physical Therapy Operations (outpatient clinics providing orthopedic and sports injury care) and Industrial Injury Prevention (IIP) services (onsite injury prevention and rehabilitation for employers). As of March 31, 2025, the Company owned or managed 736 clinics across 44 states, plus 37 managed physician-owned practices.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Revenue | $183.8 million | $155.7 million |
| Net Income (GAAP) | $13.5 million | $11.6 million |
| Net Income Attributable to USPH Shareholders | $9.9 million | $8.0 million |
| Diluted EPS | $0.80 | $0.46 |
| Adjusted EBITDA (Non-GAAP) | $19.5 million | $16.8 million |
| Operating Cash Flow | ($4.7 million) used | $4.4 million provided |
| Cash and Equivalents | $39.2 million | $132.3 million |
| Total Debt (Net) | $166.5 million | $153.5 million |
| Available Credit | $147.0 million | $164.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 18.1% year-over-year, driven by a 16.4% increase in patient visits and a 2.2% increase in net rate per visit ($105.66 vs. $103.37), despite a 2.9% Medicare rate reduction effective Jan 1, 2025.
- Profitability: Operating income rose 31.6% to $19.6 million. Gross margin decreased slightly to 16.9% from 18.2% due to clinic closure costs and higher operating expenses associated with new acquisitions.
- Cash Flow: Operating cash flow turned negative ($4.7M used) compared to positive in the prior year, primarily due to the timing of payments for payables and accrued expenses. Investing activities used $6.6 million, largely for business acquisitions.
- Debt Utilization: The Company increased borrowings on its Revolving Facility by $17.0 million to fund acquisitions, resulting in a higher total debt balance.
Guidance, Outlook, and Risks
- Acquisition Strategy: The Company continues to pursue acquisitions of outpatient physical therapy practices and IIP businesses. Notable recent activity includes a 50% stake in MSO Metro, LLC (Oct 2024) and a 65% stake in a 3-clinic practice (Feb 2025).
- Dividends: The Board declared a quarterly dividend of $0.45 per share, payable June 13, 2025.
- Regulatory Risks: The Company faces ongoing risks related to Medicare reimbursement rate reductions, changes in CMS rules, and potential audits or investigations by federal and state agencies (e.g., False Claims Act).
- Contingent Consideration: Significant gains ($4.8 million) were recognized from the change in fair value of contingent earn-out consideration, which can introduce volatility to earnings.
- Redeemable Non-Controlling Interest: The Company holds significant redeemable non-controlling interests ($260.0 million), which are subject to redemption based on earnings multiples upon specific triggering events (e.g., termination of employment).
Investor Verification Checklist
- Cash Flow Sustainability: Verify the reasons for the shift from positive to negative operating cash flow and assess the impact on liquidity given the high level of redeemable non-controlling interest obligations.
- Acquisition Integration: Review the performance of recent large acquisitions (e.g., Metro, LLC) to ensure they are meeting the earn-out criteria and contributing to organic growth.
- Medicare Impact: Monitor the actual financial impact of the 2.9% Medicare rate reduction on the net rate per visit in subsequent quarters.
- Debt Covenants: Confirm continued compliance with the Consolidated Leverage Ratio and Fixed Charge Coverage Ratio covenants under the Credit Agreement, especially as debt levels rise.
- Contingent Liabilities: Assess the potential cash outflow required for the $260 million in redeemable non-controlling interests if triggering events occur.